ArticlebioRxiv : the preprint server for biology2026
Structure basis for single-strand nucleic acid targeting by IscB and variants.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
4 authors.
Funding
Abstract
Transposon-encoded IscB has been established as the evolutionary ancestor of CRISPR-Cas9. This compact RNA-guided endonuclease has since been engineered for genome editing applications. We previously repurposed IscB and Cas9 as efficient RNA editors by removing their double-stranded DNA recognition module, the TAM/PAM-interacting domain. Here, we report four cryo-EM structures of IscB in complex with single-stranded nucleic acid (ssNA) targets to illuminate its mechanistic underpinnings. Structural analysis reveals that IscB initially facilitates formation of a 10-nt seed duplex with ssNA; however, further base-pairing is blocked by an alternatively positioned HNH nuclease that acts as a conformational roadblock. In this intermediate state, neither HNH nor RuvC is competent for target cleavage: the HNH domain is occluded by the roadblock configuration, while the RuvC active site is obstructed by the guide RNA. Only upon full duplex formation do additional base pairs between the guide RNA and ssNA dislodge the HNH roadblock, simultaneously exposing the RuvC nuclease active site. We propose that an analogous conformational checkpoint governs IscB activity during dsDNA target interrogation. Guided by these structural insights, we introduced mutations to either enhance ssNA binding or relieve the conformational checkpoint, both of which significantly improved RNA-targeting efficiency of IscB.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.